{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T23:37:43Z","timestamp":1721950663526},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To establish the reference ranges and evaluate the efficacy of the fetal facial sonomarkers prenasal thickness (PT), nasal bone length (NBL), PT\/NBL ratio and NBL\/PT ratio for Down syndrome screening in the second trimester of high-risk pregnancies using two-dimensional (2D) ultrasound.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective study was done in Thai pregnant women at high risk for structural and chromosomal abnormalities between May 2018 and May 2019. The main exclusion criteria were any fetal anatomical anomaly detected on ultrasonography or postpartum examination, abnormal chromosome or syndrome other than Down syndrome. Ultrasounds were performed in 375 pregnant women at 14 to 22\u00a0weeks\u2019 gestation and the fetal facial parameters were analyzed. Down syndrome results were confirmed by karyotyping. The reference ranges of these facial ultrasound markers were constructed based on the data of our population. The Down syndrome screening performance using these facial ultrasound markers was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 340 euploid fetuses and 11 fetuses with Down syndrome met the inclusion criteria. The PT, NBL, and PT\/NBL ratios in the euploid fetuses gradually increased with gestation progression while the NBL\/PT ratio gradually decreased between 14\u201322\u00a0weeks\u2019 gestation. The NBL, PT\/NBL ratio, and NBL\/PT ratio all had 100% sensitivity and PT had 91% sensitivity. These facial markers had 100% negative predictive value for Down syndrome screening in the second trimester. The Bland\u2013Altman analysis showed the intra- and inter-observer variations of PT and NBL had high intraclass correlation coefficients (ICC) in both operators, with ICCs of 0.98 and 0.99 and inter-observer ICCs of 0.99 for both operators.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The facial ultrasound markers are very useful for second trimester Down syndrome screening in our population. These facial ultrasound markers were easily identifiable and highly consistent either intra- or inter-operator by using widely-available 2D ultrasound. However, the reference ranges for these markers need to be constructed based on individual populations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Registration number: REC 61\u2013029-12\u20133. Date of registration: 18\u00a0May 2018.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-04332-0","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T09:03:03Z","timestamp":1641891783000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of fetal facial markers on a second trimester genetic sonogram in screening for Down syndrome in a high-risk Thai population"],"prefix":"10.1186","volume":"22","author":[{"given":"Savitree","family":"Pranpanus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanokkarn","family":"Keatkongkaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manaphat","family":"Suksai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"4332_CR1","first-page":"54","volume":"33","author":"JL Down","year":"1995","unstructured":"Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995;33:54\u20136.","journal-title":"Ment Retard"},{"key":"4332_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s004290050123","volume":"197","author":"CS von Kaisenberg","year":"1998","unstructured":"von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12\u201318 weeks and in a trisomy 16 mouse. Anat Embryol (Berl). 1998;197:105\u201324.","journal-title":"Anat Embryol (Berl)"},{"key":"4332_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1515\/JPM.2009.107","volume":"37","author":"C Bellini","year":"2009","unstructured":"Bellini C, Rutigliani M, Boccardo FM, Bonioli E, Campisi C, Grillo F, Bellini T, Valenzano M, Fulcheri E. Nuchal translucency and lymphatic system maldevelopment. J Perinat Med. 2009;37:673\u20136.","journal-title":"J Perinat Med"},{"key":"4332_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/pd.4649","volume":"35","author":"G Manegold-Brauer","year":"2015","unstructured":"Manegold-Brauer G, Bourdil L, Berg C, Schoetzau A, Gembruch U, Geipel A. Prenasal thickness to nasal bone length ratio in normal and trisomy 21 fetuses at 11\u201314 weeks of gestation. Prenat Diagn. 2015;35:1079\u201384.","journal-title":"Prenat Diagn"},{"key":"4332_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.semperi.2015.11.009","volume":"40","author":"R Rao","year":"2016","unstructured":"Rao R, Platt LD. Ultrasound screening: Status of markers and efficacy of screening for structural abnormalities. Semin Perinatol. 2016;40:67\u201378.","journal-title":"Semin Perinatol"},{"key":"4332_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000449099","volume":"43","author":"M Bakker","year":"2018","unstructured":"Bakker M, Pace M, de Jong-Pleij E, Birnie E, Kagan KO, Bilardo CM. Prenasal Thickness, Prefrontal Space Ratio and Other Facial Profile Markers in First-Trimester Fetuses with Aneuploidies, Cleft Palate, and Micrognathia. Fetal Diagn Ther. 2018;43:231\u201340.","journal-title":"Fetal Diagn Ther"},{"key":"4332_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejogrb.2015.05.011","volume":"191","author":"A Tournemire","year":"2015","unstructured":"Tournemire A, Groussolles M, Ehlinger V, Lusque A, Morin M, Benevent JB, Arnaud C, Vayssiere C. Prenasal thickness to nasal bone length ratio: effectiveness as a second or third trimester marker for Down syndrome. Eur J Obstet Gynecol Reprod Biol. 2015;191:28\u201332.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4332_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/uog.7471","volume":"35","author":"EA De Jong-Pleij","year":"2010","unstructured":"De Jong-Pleij EA, Ribbert LS, Tromp E, Bilardo CM. Three-dimensional multiplanar ultrasound is a valuable tool in the study of the fetal profile in the second trimester of pregnancy. Ultrasound Obstet Gynecol. 2010;35:195\u2013200.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/uog.12364","volume":"41","author":"M Agathokleous","year":"2013","unstructured":"Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol. 2013;41:247\u201361.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/uog.14720","volume":"46","author":"FI Vos","year":"2015","unstructured":"Vos FI, de Jong-Pleij EA, Bakker M, Tromp E, Kagan KO, Bilardo CM. Fetal facial profile markers of Down syndrome in the second and third trimesters of pregnancy. Ultrasound Obstet Gynecol. 2015;46:168\u201373.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pd.4442","volume":"34","author":"A Szabo","year":"2014","unstructured":"Szabo A, Szili K, Szabo JT, Sikovanyecz J, Isaszegi D, Horvath E, Szabo J. Nasal bone length: prenasal thickness ratio: a strong 2D ultrasound marker for Down syndrome. Prenat Diagn. 2014;34:1139\u201345.","journal-title":"Prenat Diagn"},{"key":"4332_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/pd.1207","volume":"25","author":"R Maymon","year":"2005","unstructured":"Maymon R, Levinsohn-Tavor O, Cuckle H, Tovbin Y, Dreazen E, Wiener Y, Herman A. Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down syndrome screening. Prenat Diagn. 2005;25:906\u201311.","journal-title":"Prenat Diagn"},{"key":"4332_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mob.2002.119082","volume":"186","author":"JD Sonek","year":"2002","unstructured":"Sonek JD, Nicolaides KH. Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol. 2002;186:139\u201341.","journal-title":"Am J Obstet Gynecol"},{"key":"4332_CR14","doi-asserted-by":"crossref","unstructured":"Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH. Nasal bone hypoplasia in trisomy 21 at 15\u201322 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2003;21:15\u20138.","DOI":"10.1002\/uog.19"},{"key":"4332_CR15","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3109\/14767058.2014.885944","volume":"27","author":"X Yang","year":"2014","unstructured":"Yang X, Zhen L, Pan M, Han J, Li D, Liao C. PT\/NBL ratio assessment at mid-trimester in prenatal screening for Down syndrome in a Chinese population. J Matern Fetal Neonatal Med. 2014;27:1860\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4332_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.5404","volume":"32","author":"N Persico","year":"2008","unstructured":"Persico N, Borenstein M, Molina F, Azumendi G, Nicolaides KH. Prenasal thickness in trisomy-21 fetuses at 16\u201324 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32:751\u20134.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR17","doi-asserted-by":"crossref","unstructured":"Sonek J, Borenstein M, Downing C, McKenna D, Neiger R, Croom C, Genrich T, Nicolaides KH. Frontomaxillary facial angles in screening for trisomy 21 at 14\u201323 weeks\u2019 gestation. Am J Obstet Gynecol. 2007;197(160):e161-165.","DOI":"10.1016\/j.ajog.2007.03.059"},{"key":"4332_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/uog.5288","volume":"31","author":"F Molina","year":"2008","unstructured":"Molina F, Persico N, Borenstein M, Sonek J, Nicolaides KH. Frontomaxillary facial angle in trisomy 21 fetuses at 16\u201324 weeks of gestation. Ultrasound Obstet Gynecol. 2008;31:384\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/uog.11120","volume":"40","author":"J Sonek","year":"2012","unstructured":"Sonek J, Molina F, Hiett AK, Glover M, McKenna D, Nicolaides KH. Prefrontal space ratio: comparison between trisomy 21 and euploid fetuses in the second trimester. Ultrasound Obstet Gynecol. 2012;40:293\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/uog.2619","volume":"27","author":"R Maymon","year":"2006","unstructured":"Maymon R, Ushakov F, Waisman D, Cuckle H, Tovbin Y, Herman A. A model for second-trimester Down syndrome sonographic screening based on facial landmarks and digit length measurement. Ultrasound Obstet Gynecol. 2006;27:290\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/uog.13228","volume":"43","author":"M Moreno-Cid","year":"2014","unstructured":"Moreno-Cid M, Rubio-Lorente A, Rodriguez MJ, Bueno-Pacheco G, Tenias JM, Roman-Ortiz C, Arias A. Systematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome. Ultrasound Obstet Gynecol. 2014;43:247\u201353.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/GRF.0000000000000012","volume":"57","author":"J Sonek","year":"2014","unstructured":"Sonek J, Croom C. Second trimester ultrasound markers of fetal aneuploidy. Clin Obstet Gynecol. 2014;57:159\u201381.","journal-title":"Clin Obstet Gynecol"},{"key":"4332_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pd.1641","volume":"27","author":"E Jung","year":"2007","unstructured":"Jung E, Won HS, Lee PR, Kim A. Ultrasonographic measurement of fetal nasal bone length in the second trimester in Korean population. Prenat Diagn. 2007;27:154\u20137.","journal-title":"Prenat Diagn"},{"key":"4332_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejogrb.2013.08.039","volume":"171","author":"T Ozcan","year":"2013","unstructured":"Ozcan T, Ozlu T, Allen J, Peterson J, Pressman EK. Predictive role of prenasal thickness and nasal bone for Down syndrome in the second trimester. Eur J Obstet Gynecol Reprod Biol. 2013;171:220\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4332_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/uog.9047","volume":"39","author":"EA De Jong-Pleij","year":"2012","unstructured":"De Jong-Pleij EA, Vos FI, Ribbert LS, Pistorius LR, Tromp E, Bilardo CM. Prenasal thickness-to-nasal bone length ratio: a strong and simple second- and third-trimester marker for trisomy 21. Ultrasound Obstet Gynecol. 2012;39:185\u201390.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/uog.13391","volume":"45","author":"FI Vos","year":"2015","unstructured":"Vos FI, De Jong-Pleij EA, Bakker M, Tromp E, Pajkrt E, Kagan KO, Bilardo CM. Nasal bone length, prenasal thickness, prenasal thickness-to-nasal bone length ratio and prefrontal space ratio in second- and third-trimester fetuses with Down syndrome. Ultrasound Obstet Gynecol. 2015;45:211\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/pd.4521","volume":"35","author":"FI Vos","year":"2015","unstructured":"Vos FI, Bakker M, de Jong-Pleij EA, Ribbert LS, Tromp E, Bilardo CM. Is 3D technique superior to 2D in Down syndrome screening? Evaluation of six second and third trimester fetal profile markers. Prenat Diagn. 2015;35:207\u201313.","journal-title":"Prenat Diagn"},{"key":"4332_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/pd.2938","volume":"32","author":"N Persico","year":"2012","unstructured":"Persico N, Molina F, Azumendi G, Fedele L, Nicolaides KH. Nasal bone assessment in fetuses with trisomy 21 at 16\u201324 weeks of gestation by three-dimensional ultrasound. Prenat Diagn. 2012;32:240\u20134.","journal-title":"Prenat Diagn"},{"key":"4332_CR29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/jog.13636","volume":"44","author":"H Ozdemir","year":"2018","unstructured":"Ozdemir H, Kalayci H, Yetkinel S, Cok T, Coban G, Tarim E. The nomogram of prenasal thickness and nasal bone ratio and its relationship with nuchal fold in second-trimester fetal ultrasound. J Obstet Gynaecol Res. 2018;44:1063\u201371.","journal-title":"J Obstet Gynaecol Res"},{"key":"4332_CR30","doi-asserted-by":"crossref","unstructured":"Altunkeser A, Korez MK. Reference ranges for foetal nasal bone length, prenasal thickness, and interocular distance at 18 to 24 weeks\u2019 gestation in low-risk pregnancies. BMC Pregnancy Childbirth. 2017;17:416.","DOI":"10.1186\/s12884-017-1602-3"},{"key":"4332_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4332_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10198-017-0946-y","volume":"19","author":"L Garcia-Perez","year":"2018","unstructured":"Garcia-Perez L, Linertova R, Alvarez-de-la-Rosa M, Bayon JC, Imaz-Iglesia I, Ferrer-Rodriguez J, Serrano-Aguilar P. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review. Eur J Health Econ. 2018;19:979\u201391.","journal-title":"Eur J Health Econ"},{"key":"4332_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-0034-1395670","volume":"218","author":"LJ Salomon","year":"2014","unstructured":"Salomon LJ, Alfirevic Z, Audibert F, Kagan KO, Paladini D, Yeo G, Raine-Fenning N. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Z Geburtshilfe Neonatol. 2014;218:242\u20133.","journal-title":"Z Geburtshilfe Neonatol"},{"key":"4332_CR34","doi-asserted-by":"publisher","first-page":"e0251381","DOI":"10.1371\/journal.pone.0251381","volume":"16","author":"S Pranpanus","year":"2021","unstructured":"Pranpanus S, Kor-Anantakul O, Suntharasaj T, Suwanrath C, Hanprasertpong T, Pruksanusak N, Petpichetchian C, Suksai M, Chainarong N, Sawaddisan R. Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country. PLoS ONE. 2021;16:e0251381.","journal-title":"PLoS ONE"},{"issue":"5","key":"4332_CR35","doi-asserted-by":"publisher","first-page":"516.e1","DOI":"10.1016\/j.ajog.2020.10.039","volume":"224","author":"T Hu","year":"2020","unstructured":"Hu T, Tian T, Zhang Z, Wang J, Hu R, Xiao L, Zhu H, Lai Y, Wang H, Liu S. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am J Obstet Gynecol. 2020;224(5):516.e1-516.e16.","journal-title":"Am J Obstet Gynecol"},{"key":"4332_CR36","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.7863\/jum.2010.29.12.1741","volume":"29","author":"J Miguelez","year":"2010","unstructured":"Miguelez J, Moskovitch M, Cuckle H, Zugaib M, Bunduki V, Maymon R. Model-predicted performance of second-trimester Down syndrome screening with sonographic prenasal thickness. J Ultrasound Med. 2010;29:1741\u20137.","journal-title":"J Ultrasound Med"},{"key":"4332_CR37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/uog.20141","volume":"53","author":"E Lostchuck","year":"2019","unstructured":"Lostchuck E, Hui L. Should second-trimester hypoplastic nasal bone be sole indication for diagnostic testing with chromosomal microarray analysis? Ultrasound Obstet Gynecol. 2019;53:848\u201350.","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04332-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T09:03:09Z","timestamp":1641891789000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04332-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04332-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"25 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board, Office of the Human Research Ethics Committee (HREC), Faculty of Medicine, Prince of Songkla University.Approval Number: REC.61\u2013029-12\u20133.All of the patients who participated in this study were informed of the study design and aims and gave their written informed consent.All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}